Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy

Antiviral Therapy

Volumn 9, Issue 1, 2004, Pages 67-75

  Pires, Antonio ^a   Pido Lopez, Jeffrey ^a   Moyle, Graeme ^a   Gazzard, Brian ^a   Gotch, Frances ^a   Imami, Nesrina ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; HUMAN GROWTH HORMONE; PLACEBO; VIRUS ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE REGIMEN; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; IMMUNOTHERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; HIV-1; HUMAN GROWTH HORMONE; HUMANS; LYMPHOCYTE ACTIVATION; PLACEBOS; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 1542349076     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P & Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell home-ostasis and function in advanced HIV disease. Science 1997; 277:112-116.
2. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD & Siliciano RE Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-1300.
3. McMichael AJ & Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-987.
4. Wilson JD, Imami N, Watkins A, Gill J, Hay P, Gazzard B, Westby M & Gotch FM. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. Journal of Infectious Diseases 2000; 182:792-798.
5. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ & Rowland-Jones SL. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. Journal of Experimental Medicine 2000; 192:63-75.
6. Gurley RJ, Ikeuchi K, Byrn RA, Anderson K & Groopman JE. CD4+ lymphocyte function with early human immunodeficiency virus infection. Proceedings of the National Academy of Sciences, USA 1989; 86:1993-1997.
7. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. Journal of Clinical Investigation 1988; 82:1908-1914.
8. Musey LK, Krieger JN, Hughes JP, Schacker TW, Corey L & McElrath MJ. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. Journal of Infectious Diseases 1999; 180:278-284.
9. Sallusto F, Lenig D, Forster R, Lipp M & Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
10. Geginat J, Lanzavecchia A & Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101:4260-4266.
11. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S & Connors M. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunology 2002; 3:1061-1068.
12. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, Forster R, Rowland-Jones S, Sekaly RP, McMichael AJ & Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-111.
13. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, Casazza J, Yoder C, Adelsberger JW, Stevens RA, Baseler MW, Keiser P, Richman DD, Davey RT & Koup RA. Evidence for increased T cell turnover and decreased thymic output in HIV infection. Journal of Immunology 2001; 167:6663-6668.
14. Haynes BF, Markert ML, Sempowski GD, Patel DD & Hale LP. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annual Review of Immunology 2000; 18:529-560.
15. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. Journal of Experimental Medicine 1993; 178:1151-1163.
16. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM & Kaneshima H. HIV induces thymus depletion in vivo. Nature 1993; 363:728-732.
17. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L & McCune JM. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995; 2:25-36.
18. Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S, Vesanen M, Spiegel H, Kost R, van Lunzen J, Stellbrink HJ, Wolinsky S, Borkowsky W, Palumbo P, Kostrikis LG & Ho DD. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. Journal of Experimental Medicine 1999; 190:725-732.
19. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ & Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695.
20. Koo GC, Huang C, Camacho R, Trainor C, Blake JT, Sirotina-Meisher A, Schleim KD, Wu TJ, Cheng K, Nargund R & McKissick G. Immune enhancing effect of a growth hormone secretagogue. Journal of Immunology 2001; 166:4195-4201.
21. Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF & Dardenne M. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. Journal of Clinical Endocrinology & Metabolism 1992; 75:183-188.
22. Mocchegiani E, Paolucci P, Balsamo A, Cacciari E & Fabris N. Influence of growth hormone on thymic endocrine activity in humans. Hormone Research 1990; 33:248-255.
23. Murphy WJ, Durum SK & Longo DL. Differential effects of growth hormone and prolactin on murine T cell development and function. Journal of Experimental Medicine 1993; 178:231-236.
24. Dardenne M, Mello-Coelho V, Gagnerault MC & Postel-Vinay MC. Growth hormone receptors and immunocompetent cells. Annals of the New York Academy of Sciences 1998; 840:510-517.
25. Hirokawa K, Utsuyama M & Kobayashi S. Hypothalamic control of thymic function. Cellular & Molecular Biology (Noisy-le-grand) 2001; 47:97-102.
26. Tozser J. HIV inhibitors: problems and reality. Annals of the New York Academy of Sciences 2001; 946:145-159.
27. Imami N, Larche M & Ritter MA. Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4- producing human T cells. International Immunology 1994; 6:1575-1584.
28. Imami N, Hardy GA, Nelson MR, Morris-Jones S, Al-Shahi R, Antonopoulos C, Gazzard B & Gotch FM. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy. Clinical & Experimental Immunology 1999; 118:78-86.
29. Aspinall R, Pido J & Andrew D. A simple method for the measurement of sjTREC levels in blood. Mechanisms of Ageing & Development 2000; 121:59-67.
30. Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D & Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Polspecific CD8 T cells in HIV-1-positive individuals. AIDS 1999; 13:767-777.
31. Cohen Stuart JW, Hamann D, Borleffs JC, Roos M, Miedema F, Boucher CA & Boer R. Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS 2002; 16:2263-2266.
32. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U & Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. Journal of Immunology 1984; 133:1710-1715.
33. Schoenberger SP, Jonges LE, Mooijaart RJ, Hartgers F, Toes RE, Kast WM, Melief CJ & Offringa R. Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC. Cancer Research 1998; 58:3094-3100.
34. Bergholtz BO & Thorsby E. Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scandinavian Journal of Immunology 1977; 6:779-786.
35. Wanke C, Gerrior J, Kantaros J, Coakley E & Albrecht M. Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS 1999; 13:2099-2103.
36. Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M & McCune JM. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 2002; 16:1103-1111.
37. Welniak LA, Sun R & Murphy WJ. The role of growth hormone in T-cell development and reconstitution. Journal of Leukocyte Biology 2002; 71:381-387.
38. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS & Gress RE. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-3707.
39. Mackall CL, Hakim FT & Gress RE. T-cell regeneration: all repertoires are not created equal. Immunology Today 1997; 18:245-251.
40. Brenchley JM, Douek DC, Ambrozak DR, Chatterji M, Betts MR, Davis LS & Koup RA. Expansion of activated human naive T-cells precedes effector function. Clinical Experimental Immunology 2002; 130:432-440.
41. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M & Akbar AN. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. Journal of Immunology 1998; 161:5909-5917.
42. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ & Rowland-Jones SL. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Medicine 2002; 8:379-385.
43. Wodarz D & Jansen VA. The role of T cell help for antiviral CTL responses. Journal of Theoretical Biology 2001; 211:419-432.
44. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ & Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clinical Experimental Immunology 1992; 90:376-382.
45. Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J & Phair JP. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. Journal of Infectious Diseases 1994; 170:775-781.